Tempest Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Tempest Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2013 to 2023.
  • Tempest Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $450K, a 923% increase year-over-year.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $35.6M, a 212% increase from 2022.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.4M, a 80.7% decline from 2021.
  • Tempest Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $59.1M, a 70.7% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $35.6M +$24.2M +212% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $11.4M -$47.7M -80.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $59.1M +$24.5M +70.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $34.6M +$7.66M +28.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $26.9M -$50.8M -65.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $77.7M +$82.2M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$4.46M -$58.6M -108% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $54.1M -$71.2M -56.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $125M +$73.7M +142% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $51.7M +$19.3M +59.5% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $32.4M Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.